Renfeng Liu
Overview
Explore the profile of Renfeng Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Wu W, Jia S, Xu H, Gao Z, Wang Z, Lu B, et al.
ACS Nano
. 2023 Feb;
17(4):3818-3837.
PMID: 36787636
Neural stem cells (NSCs) are considered to be prospective replacements for neuronal cell loss as a result of spinal cord injury (SCI). However, the survival and neuronal differentiation of NSCs...
22.
Sun J, Qian X, Zhang F, Tang X, Ju C, Liu R, et al.
Transl Cancer Res
. 2022 Feb;
8(8):2759-2768.
PMID: 35117033
Background: WT161 is a recently discovered histone deacetylase 6 (HDAC6) inhibitor which shows anti-tumor effects on multiple myelomas and breast cancer. However, the role of WT161 in retinoblastoma remains unclear....
23.
Lv B, Gao G, Guo Y, Zhang Z, Liu R, Dai Z, et al.
Aging (Albany NY)
. 2021 Sep;
13(17):21142-21154.
PMID: 34493692
Background: Osteosarcoma (OS) is a common disease in the world, and its pathogenesis is still unclear. This study aims to identify the key genes that promote the proliferation, invasion, and...
24.
Zhang F, Tang X, Fan S, Liu X, Sun J, Ju C, et al.
Oncogene
. 2021 May;
40(24):4137-4150.
PMID: 34017080
BRAF inhibitors (BRAFi) that target BRAF V600E kinase, a driver mutation found in 50% of melanomas, show a significant antitumor response, but the common emergence of acquired resistance remains a...
25.
Sun J, Wu W, Tang X, Zhang F, Ju C, Liu R, et al.
Biosci Rep
. 2021 Apr;
41(4).
PMID: 33860796
Background: WT161, as a selective HDAC6 inhibitor, has been shown to play anti-tumor effects on several kinds of cancers. The aim of the present study is to explore the roles...
26.
Guo Y, Lv B, Liu R, Dai Z, Zhang F, Liang Y, et al.
Cancer Cell Int
. 2021 Apr;
21(1):209.
PMID: 33849550
The metabolic change of tumor cells is an extremely complicated process that involves the intersection and integration of various signal pathways. Compared with normal tissues, cancer cells show distinguished metabolic...
27.
Liu R, Ju C, Zhang F, Tang X, Yan J, Sun J, et al.
Biochem Biophys Res Commun
. 2020 Sep;
532(2):300-307.
PMID: 32868080
Background: Long noncoding RNAs (LncRNAs) show dysregulation in a variety of cancers. However, the function and specific mechanism of LncRNA GSEC in the progression of osteosarcoma remain mostly unknown. In...
28.
An H, Guo C, Li D, Liu R, Xu X, Guo J, et al.
ACS Appl Mater Interfaces
. 2020 Mar;
12(15):17230-17243.
PMID: 32193923
Abnormally increased reactive oxygen species (ROS) are intimately related to the development and metastasis of cancer. Since hydrogen peroxide (HO) is a major component of ROS, molecular imaging and selective...
29.
Zhou R, Tang X, Li L, Zhang F, Sun J, Ju C, et al.
Cancer Manag Res
. 2020 Feb;
12:531-539.
PMID: 32021462
Introduction: Breast cancer metastasis suppressor 1 like (BRMS1-like)was first reported to be a component of the Sin3-HDAC complex, but the role in the progression of cancers was largely unknown. Our...
30.
Ju C, Liu R, Zhang Y, Zhang F, Sun J, Lv X, et al.
Biomed Res Int
. 2019 Nov;
2019:7695768.
PMID: 31781642
Osteoarthritis (OA) is a joint degenerative disease, which is prominent in the middle-aged and elderly population, often leading to repeated pain in the joints of patients and seriously affecting the...